CSL Ltd (ASX: CSL) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.CSL Limited (ASX: CSL) Latest News
CSL (ASX:CSL) share price falls amid ongoing AstraZeneca uncertainty
Lucas Radbourne | April 13, 2021 11:03am
Trashed COVID-19 vaccine targets hit ASX travel shares
Mitchell Lawler | April 12, 2021 3:50pm
How you can become rich buying and holding ASX shares
James Mickleboro | April 12, 2021 3:30pm
Is the CSL (ASX:CSL) share price too cheap to ignore?
James Mickleboro | April 11, 2021 10:08am
CSL (ASX:CSL) share price dips on latest AstraZeneca news
Marc Sidarous | April 9, 2021 12:15pm
CSL (ASX:CSL) share price wobbles on COVID vaccine news
Marc Sidarous | April 8, 2021 10:50am
Dividend Payment History
Data provided by Morningstar.| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Mar 2021 | $1.3491 | 0.00% | Interim | 01 Apr 2021 |
| 10 Sep 2020 | $1.4696 | 0.00% | Final | 09 Oct 2020 |
| 11 Mar 2020 | $1.4713 | 0.00% | Interim | 09 Apr 2020 |
| 10 Sep 2019 | $1.4545 | 0.00% | Final | 11 Oct 2019 |
| 13 Mar 2019 | $1.2032 | 0.00% | Interim | 12 Apr 2019 |
| 11 Sep 2018 | $1.2782 | 0.00% | Final | 12 Oct 2018 |
| 14 Mar 2018 | $1.0050 | 0.00% | Interim | 13 Apr 2018 |
| 12 Sep 2017 | $0.9153 | 0.00% | Final | 13 Oct 2017 |
| 15 Mar 2017 | $0.8378 | 0.00% | Interim | 13 Apr 2017 |
| 13 Sep 2016 | $0.8867 | 0.00% | Final | 07 Oct 2016 |
| 23 Mar 2016 | $0.8147 | 0.00% | Interim | 15 Apr 2016 |
| 07 Sep 2015 | $0.8999 | 0.00% | Final | 02 Oct 2015 |
| 16 Mar 2015 | $0.7439 | 0.00% | Interim | 10 Apr 2015 |
| 08 Sep 2014 | $0.6485 | 0.00% | Final | 03 Oct 2014 |
| 05 Mar 2014 | $0.5888 | 0.00% | Interim | 04 Apr 2014 |
| 09 Sep 2013 | $0.5698 | 0.00% | Final | 04 Oct 2013 |
| 05 Mar 2013 | $0.4866 | 0.00% | Interim | 05 Apr 2013 |
| 17 Sep 2012 | $0.4700 | 0.00% | Final | 12 Oct 2012 |
| 14 Mar 2012 | $0.3600 | 0.00% | Interim | 13 Apr 2012 |
| 19 Sep 2011 | $0.4500 | 4.44% | Final | 14 Oct 2011 |
| 08 Mar 2011 | $0.3500 | 0.00% | Interim | 08 Apr 2011 |
| 13 Sep 2010 | $0.4500 | 11.73% | Final | 08 Oct 2010 |
| 09 Mar 2010 | $0.3500 | 0.00% | Interim | 09 Apr 2010 |
| 14 Sep 2009 | $0.4000 | 0.00% | Final | 09 Oct 2009 |
| 17 Sep 2007 | $0.5500 | 50.00% | Final | 12 Oct 2007 |
| 30 Aug 2005 | $0.1000 | 17.80% | Special | 10 Oct 2005 |
Yearly Dividend Payment Chart
Data provided by Morningstar.Recent Stock Announcements
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About CSL Ltd (ASX: CSL)
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health and help people with life-threatening medical conditions live full lives.
While the company has been in operation for more than a century, CSL shares were first listed on the ASX in 1994 within the healthcare sector – today, CSL sits as one of the largest companies on the ASX. The CSL share price has risen exponentially since first listing on the ASX and is now considered a traditional growth stock – CSL is known to lift profit, year-on-year, and invest much of it back into research and development and capital expenditure.
CSL’s operational businesses include CSL Behring and Seqirus, and the company operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 16 Apr 2021 | $269.07 | $0.78 | 0.29% | 1,130,986 | $268.75 | $269.33 | $267.11 |
| 15 Apr 2021 | $268.29 | $0.49 | 0.18% | 554,041 | $266.57 | $268.56 | $263.26 |
| 14 Apr 2021 | $267.80 | $3.14 | 1.19% | 569,980 | $266.63 | $268.17 | $264.32 |
| 13 Apr 2021 | $264.66 | $-0.84 | -0.32% | 485,631 | $265.93 | $267.86 | $264.04 |
| 12 Apr 2021 | $265.50 | $2.10 | 0.80% | 455,820 | $263.97 | $265.79 | $263.50 |
| 09 Apr 2021 | $263.40 | $-2.54 | -0.96% | 596,694 | $263.84 | $266.60 | $262.28 |
| 08 Apr 2021 | $265.94 | $2.95 | 1.12% | 520,729 | $264.78 | $265.94 | $262.10 |
| 07 Apr 2021 | $262.99 | $-0.61 | -0.23% | 780,977 | $264.00 | $266.48 | $262.03 |
| 06 Apr 2021 | $263.60 | $0.60 | 0.23% | 820,936 | $263.25 | $264.85 | $261.57 |
| 01 Apr 2021 | $263.00 | $-1.65 | -0.62% | 615,339 | $267.00 | $267.00 | $261.93 |
| 31 Mar 2021 | $264.65 | $1.99 | 0.76% | 775,013 | $264.90 | $266.99 | $262.52 |
| 30 Mar 2021 | $262.66 | $-2.73 | -1.03% | 483,113 | $265.94 | $268.83 | $262.66 |
| 29 Mar 2021 | $265.39 | $-2.07 | -0.77% | 436,732 | $267.66 | $268.68 | $265.02 |
| 26 Mar 2021 | $267.46 | $-2.37 | -0.88% | 554,184 | $270.27 | $270.53 | $265.24 |
| 25 Mar 2021 | $269.83 | $3.81 | 1.43% | 950,338 | $265.23 | $270.92 | $264.80 |
| 24 Mar 2021 | $266.02 | $5.02 | 1.92% | 847,739 | $262.78 | $267.96 | $260.93 |
| 23 Mar 2021 | $261.00 | $0.84 | 0.32% | 532,443 | $260.94 | $262.38 | $256.50 |
| 22 Mar 2021 | $260.16 | $6.21 | 2.45% | 549,731 | $255.01 | $261.09 | $252.52 |
| 19 Mar 2021 | $253.95 | $-2.14 | -0.84% | 2,299,007 | $255.00 | $255.60 | $251.91 |
| 18 Mar 2021 | $256.09 | $-4.91 | -1.88% | 939,520 | $265.00 | $265.10 | $255.70 |
| 17 Mar 2021 | $261.00 | $-0.81 | -0.31% | 576,522 | $261.26 | $262.72 | $258.78 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| Hsbc Custody Nominees (Australia) Limited | 154,130,927 | 33.95% |
| J P Morgan Nominees Australia Pty Limited | 81,317,162 | 17.91% |
| Citicorp Nominees Pty Limited | 33,409,768 | 7.36% |
| National Nominees Limited | 12,932,543 | 2.85% |
| BNP Paribas Nominees Pty Ltd | 7,884,394 | 1.74% |
| Bnp Paribas Noms Pty Ltd | 5,625,521 | 1.24% |
| Citicorp Nominees Pty Limited I | 4,314,290 | 0.95% |
| Hsbc Custody Nominees (Australia) Limited I | 2,547,501 | 0.56% |
| Australian Foundation Investment Company Limited | 2,012,754 | 0.44% |
| Netwealth Investments Limited | 1,499,000 | 0.33% |
| Custodial Services Limited | 1,386,344 | 0.31% |
| Solium Nominees (Australia) | 1,365,798 | 0.30% |
| Argo Investments Limited | 1,113,370 | 0.25% |
| Hsbc Custody Nominees (Australia) Limited II | 866,277 | 0.19% |
| Hsbc Custody Nominees (Australia) Limited III | 857,419 | 0.19% |
| D W S Nominees Pty Ltd | 793,090 | 0.17% |
| Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 724,197 | 0.16% |
| Amp Life Limited | 704,273 | 0.16% |
| Mutual Trust Pty Ltd | 652,588 | 0.14% |
| Navigator Australia Ltd | 608,222 | 0.13% |
FAQ
What was CSL's float price?
CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks the company has embarked on, the adjusted entry price is equivalent to around 76 cents. Given CSL’s current share price, original shareholders would be very pleased!
Will CSL pay a dividend in 2020?
CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent with all dividends since 2012 having been unfranked. CSL paid an interim dividend of $1.47 on 9 April 2020 and is scheduled to pay its final dividend early to mid-October.
Does CSL offer a DRP?
CSL has a dividend reinvestment plan however it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.